Retinal vasculature in hypertension
高血压患者的视网膜血管
基本信息
- 批准号:10367158
- 负责人:
- 金额:$ 36.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdhesionsAdultAngiotensin IIAntihypertensive AgentsAreaBasement membraneBlood PlateletsBlood PressureBlood VesselsBlood capillariesBlood flowBlood-Retinal BarrierCD31 AntigensChronicCollagenConnexin 43DataDependenceDesminDevelopmentDiseaseE-SelectinEndothelial CellsEndothelin-1EndotheliumEventExtracellular MatrixEyeFemaleFibronectinsFunctional disorderFutureGlycocalyxGlycoproteinsGlypicanGonadal Steroid HormonesHealthHemorrhageHypertensionHypertensive RetinopathyHypoxiaInbred SHR RatsInbred WKY RatsKDR geneKnowledgeLeadLeukocytesMediator of activation proteinMesenchymalMicrocirculationModelingMolecularN-CadherinNamesOptic DiskOxygenPathologicPathway interactionsPerfusionPharmaceutical PreparationsPharmacologyPhenotypePlatelet GlycoproteinsPopulationPredispositionPrevalenceProteoglycanRecoveryRetinaRetinal Artery OcclusionRetinal DiseasesRisk FactorsS100A4 geneSmooth MuscleSmooth Muscle MyocytesSurfaceSwellingTestingThinnessThrombusUnited StatesVasodilationVimentinVisionWorkarterioleblood pressure reductioncadherin 5collagenasecotton wool spotsdriving forceendothelial dysfunctionexperimental studyhypertensivemalemoesinmuscle degenerationnegative affectnormotensivenovelpressurepreventresponseretina blood vessel structureretina circulationretinal neuronsexsyndecantherapeutically effectivevein occlusionvon Willebrand factor receptor
项目摘要
Approximately 32-44% of the adult US population has hypertension, with one of the many complications
being hypertensive retinopathy. In one study, the prevalence of retinopathy was found to be 85% amongst
those with severe hypertension, and 25% for those with mild hypertension. Retinal consequences of
hypertension include arteriolar narrowing, hemorrhages, cotton wool spots (localized hypoxia), and optic
disk swelling. Other retinal changes include hyalinization of arteriolar walls, thickening of the vascular
basement membrane, closure of capillaries, smooth muscle degeneration, and blood-retinal barrier
dysfunction. Additionally, hypertension is a major risk factor for the highly threatening events of retinal artery
or vein occlusion. The primary treatment for hypertensive retinopathy is to reduce blood pressure; however,
consequences of the disease including narrowing of arterioles persist even following anti-hypertension
medication. Therefore, a better knowledge of the mechanisms of the disease could lead to the development
of additional and more effective therapeutic options. Our overall hypothesis is that the vascular
complications of hypertensive retinopathy are due phenotypic changes in endothelial and smooth muscle
cells, with vessel wall remodeling limiting recovery even with anti-hypertensive medication. The specific
aims are to: (1) determine the sex-dependent expression of the glycocalyx in the retina, and determine the
consequences of hypertension on this expression, (2) examine the sex-dependent expression of platelet
endothelial adhesion molecule-1 and vascular endothelial cadherin in the retina, and test the hypothesis
that changes in these junctional molecules in the hypertensive retina are due to endothelial-to-
mesenchymal transition, and (3) test the hypothesis that remodeling of blood vessel walls in the SHR retina
induces susceptibility to poor retinal perfusion when high blood pressure is reduced to normal.
大约 32-44% 的美国成年人患有高血压,这是众多并发症之一
是高血压性视网膜病变。一项研究发现,视网膜病变的患病率为 85%
重度高血压患者占25%,轻度高血压患者占25%。视网膜后果
高血压包括小动脉狭窄、出血、棉絮斑(局部缺氧)和视神经
椎间盘肿胀。其他视网膜变化包括小动脉壁玻璃样变、血管增厚
基底膜、毛细血管闭合、平滑肌变性和血视网膜屏障
功能障碍。此外,高血压是视网膜动脉高度威胁事件的主要危险因素
或静脉阻塞。高血压性视网膜病变的主要治疗方法是降低血压;然而,
即使在抗高血压治疗后,疾病的后果(包括小动脉狭窄)仍然存在
药物。因此,更好地了解该疾病的机制可能会导致疾病的发展
额外和更有效的治疗选择。我们的总体假设是,血管
高血压视网膜病变的并发症是由于内皮细胞和平滑肌的表型变化所致
细胞,即使使用抗高血压药物,血管壁重塑也会限制恢复。具体的
目的是:(1)确定视网膜中糖萼的性别依赖性表达,并确定
高血压对此表达的影响,(2)检查血小板的性别依赖性表达
视网膜中的内皮粘附分子-1和血管内皮钙粘蛋白,并检验假设
高血压视网膜中这些连接分子的变化是由于内皮细胞与
间充质转化,以及(3)检验 SHR 视网膜中血管壁重塑的假设
当高血压降至正常时,会导致视网膜灌注不良。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NORMAN R HARRIS其他文献
NORMAN R HARRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NORMAN R HARRIS', 18)}}的其他基金
相似国自然基金
人胎盘水凝胶类器官贴片重建子宫内膜对重度宫腔粘连的作用及机制研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ROS清除型动态粘附水凝胶的制备及其在声带粘连防治中的作用与机制研究
- 批准号:82301292
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于“胞宫藏泻”理论探讨补肾养营活血方和HuMSCs调节ERS介导的细胞焦亡重塑粘连宫腔内膜容受态的研究
- 批准号:82305302
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Bone Sialoprotein in Modulating Periodontal Development and Repair
骨唾液酸蛋白在调节牙周发育和修复中的作用
- 批准号:
10752141 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Role of alveolar fibroblasts in extracellular matrix organization and alveolar type 1 cell differentiation
肺泡成纤维细胞在细胞外基质组织和肺泡1型细胞分化中的作用
- 批准号:
10731854 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Mechanisms Underpinning Afterload-Induced Atrial Fibrillation
后负荷诱发心房颤动的机制
- 批准号:
10679796 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Development and Translation of Granulated Human-Derived Biomaterials for Integrative Cartilage Repair
用于综合软骨修复的颗粒状人源生物材料的开发和转化
- 批准号:
10718170 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别: